Galectin‐3 Is Associated With Stage B Metabolic Heart Disease and Pulmonary Hypertension in Young Obese Patients

BACKGROUND: Obesity is a precursor to heart failure with preserved ejection fraction. Biomarkers that identify preclinical metabolic heart disease (MHD) in young obese patients would help identify high‐risk individuals for heart failure prevention strategies. We assessed the predictive value of GAL3...

Descripción completa

Detalles Bibliográficos
Autores principales: Gopal, Deepa M., Ayalon, Nir, Wang, Yi‐Chih, Siwik, Deborah, Sverdlov, Aaron, Donohue, Courtney, Perez, Alejandro, Downing, Jill, Apovian, Caroline, Silva, Vanessa, Panagia, Marcello, Kolachalama, Vijaya, Ho, Jennifer E., Liang, Chang‐seng, Gokce, Noyan, Colucci, Wilson S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6509711/
https://www.ncbi.nlm.nih.gov/pubmed/30929550
http://dx.doi.org/10.1161/JAHA.118.011100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6509711/
https://www.ncbi.nlm.nih.gov/pubmed/30929550
http://dx.doi.org/10.1161/JAHA.118.011100

Ejemplares similares